The focus of this study was to understand the function of STK17B in T cells, as studies on T cells from STK17B knockout mice have demonstrated a lower threshold for TCR stimulation and that they can respond to suboptimal antigens, pointing to potential utility in cancer immunotherapy (3). Here, STK17B is linked to cancer.